Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProteome Regulatory News (PRM)

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.61    0.205 (12.81%)
Bid:
1.61
Ask:
2.00
Spread: 0.39 (24.224%)
Market Cap: £5.65m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Holding(s) in Company

1 Apr 2008 15:20

TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying Proteome Securities Plc issuer of existing shares to which voting

rights are attached:

2. Reason for the notification (please tick the appropriate box or

boxes) An acquisition or disposal of voting rights

Yes

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are

attached

An event changing the breakdown of voting rights 3. Full name of person(s) subject to the Cubana Investments Limited

notification obligation:

4. Full name of shareholder(s) (if different

from 3.):

5. Date of the transaction (and date on which 01 April 2008 the threshold is crossed or reached if

different):

6. Date on which issuer notified: 01 April 2008 7. Threshold(s) that is/are crossed or reached: >8%

8. Notified details:

A: Voting rights attached to shares

Class/type Situation previous Resulting situation after the triggering of shares to the Triggering transaction transaction if possible using the ISIN CODE Number of Number of Number of Number of voting % of voting Shares Voting shares rights rights Rights Direct Indirect Direct Indirect

GB0003104196 10,374,272 10,374,272 10,531,272 10,531,272 10,531,272

8.01% B: Financial Instruments

Resulting situation after the triggering transaction

Type of Expiration Exercise/ Number of voting % of voting financial date Conversion Period/ rights that may be rights instrument Date acquired if the instrument is exercised/ converted N/A N/A N/A N/A N/A Total (A+B) Number of voting rights % of voting rights 10,531,272 8.01

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

N/A Proxy Voting: 10. Name of the proxy holder: N/A

11. Number of voting rights proxy holder will N/A

cease to hold:

12. Date on which proxy holder will cease to hold N/A

voting rights: 13. Additional Information Contact name: James Malthouse Contact Telephone number: +44 1932 865065

Note: Annex should only be submitted to the FSA not the issuer

Annex: Notification Of Major Interests In Shares

A: Identity of the person or legal entity subject to the notification

obligation

Full name (including legal form for legal Cubana Investments Limited

entities) Contact address (registered office for PO Box 957, Offshore Incorporationslegal entities) Centre, Road Town, Tortola, British Virgin Islands

Other useful information (at least legal representative for legal persons) B: Identity of the notifier, if applicable

Full name Mirza Rahman Contact address 2 Battery Road, #26-01 Maybank Tower, Singapore 049907 Phone number +65 65381998 : msrahman@artradis.com

Other useful information (e.g. functional Compliance Officer relationship with the person or legal entity subject to the notification

obligation) C: Additional information

PROTEOME SCIENCES PLC
Date   Source Headline
1st Jun 20267:00 amRNSDirectorate Changes
14th May 202612:55 pmRNSResult of AGM
14th May 202612:00 pmRNSAnnual General Meeting Statement
15th Apr 20267:00 amRNSFinal results for the year ended 31 December 2025
4th Feb 202611:08 amRNSHolding(s) in Company
3rd Feb 202612:43 pmRNSHolding(s) in Company
28th Jan 20263:31 pmRNSResult of Oversubscribed Retail Offer
26th Jan 20267:05 amRNSRetail Offer to raise up to £60,000
26th Jan 20267:00 amRNS£840,000 Fundraise and Retail Offer
6th Jan 20267:00 amRNSTwo Further Substantial Contracts for PRM
8th Dec 20257:00 amRNSSubstantial contract for Proteome Sciences
25th Nov 20257:00 amRNSAppointment of Nominated Adviser and Broker
25th Sep 20257:00 amRNSInterim Results
16th May 20251:17 pmRNSResult of AGM
16th May 202512:00 pmRNSAGM Statement
10th Apr 20257:00 amRNSFinal Results
4th Apr 20251:00 pmRNSNotice of Results and Investor Presentation
21st Feb 20257:00 amRNSContract Win
23rd Dec 20247:08 amRNSLoan Facility, Trading Update & Directorate Change
13th Sep 20247:00 amRNSInterim Results and Directorate Change
16th May 20241:10 pmRNSResult of AGM
16th May 20247:00 amRNSAGM Statement
26th Apr 20247:00 amRNSContract Win
10th Apr 20247:00 amRNSFinal Results
2nd Jan 20247:00 amRNSCompletion of new facility in San Diego
30th Nov 20237:00 amRNSTrading Update
2nd Oct 20237:00 amRNSLaunch of Single Cell Proteomics Services
30th Aug 20232:14 pmRNSInvestor Presentation
25th Aug 20237:00 amRNSInterim Results
1st Jun 20239:43 amRNSRepayment of Loan
17th May 20231:05 pmRNSResult of AGM
17th May 20237:00 amRNSAGM Statement
12th May 20237:00 amRNSExpansion into the US
14th Apr 202310:45 amRNSDirector/PDMR Shareholding
6th Apr 202311:34 amRNSDirector/PDMR Shareholding
6th Apr 202310:30 amRNSInvestor Presentation
4th Apr 20237:00 amRNSFinal Results
29th Mar 20237:00 amRNSNotice of Results
6th Mar 20234:35 pmRNSPrice Monitoring Extension
20th Feb 20237:00 amRNSTrading Update
5th Jan 20237:00 amRNSMilestone Payment for TMT®/TMTpro™ Sales
1st Dec 20224:38 pmRNSGrant of Options and PDMR/director shareholdings
12th Oct 20227:00 amRNSGrant of Options and PDMR/director shareholdings
4th Oct 20227:00 amRNSChange of Auditor
20th Sep 20224:40 pmRNSSecond Price Monitoring Extn
20th Sep 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20227:00 amRNSAppointment of Chief Financial Officer
11th Aug 20227:00 amRNSInvestor Presentation
4th Aug 20227:00 amRNSInterim Results
3rd Aug 20227:00 amRNSMilestone towards Single Cell Proteomics services

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.